Delcath Systems Net Long-Term Debt 2010-2024 | DCTH
Delcath Systems Annual Net Long-Term Debt (Millions of US $) |
|
---|---|
2024 | $-11 |
2023 | $-6 |
2022 | $N/A |
2021 | $14 |
2020 | $0 |
2019 | $4 |
2018 | $N/A |
2017 | $N/A |
2016 | $N/A |
2015 | $N/A |
2014 | $N/A |
2013 | $N/A |
2012 | $N/A |
2011 | $N/A |
2010 | $N/A |
2009 | $N/A |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | MED INSTRUMENTS | $0.404B | $0.037B |
Delcath Systems, Inc. has developed a system, the Delcath system, to isolate the liver from the general circulatory system and to administer chemotherapy and other therapeutic agents directly to the liver. |